Literature DB >> 20571093

Gitelman syndrome in Gypsy paediatric patients carrying the same intron 9 + 1 G>T mutation. Clinical features and impact on quality of life.

José David Herrero-Morín1, Julián Rodríguez, Eliecer Coto, Helena Gil-Peña, Victoria Alvarez, Laura Espinosa, César Loris, Marta Gil-Calvo, Fernando Santos.   

Abstract

BACKGROUND: Gitelman syndrome is a primary tubular disorder causing hypokalaemic metabolic alkalosis with hypocalciuria. Its prevalence is high in Gypsies, who harbour an identical mutation, intron 9 + 1 G>T, in the SLC12A3 gene.
METHODS: To better define the Gitelman syndrome in Gypsies, the clinical and biochemical features of 34 Spanish paediatric Gypsy patients were analysed. At diagnosis, symptoms, height and weight as well as serum and urinary biochemical data were collected. During a follow-up of 4.5 ± 2.4 years [X ± standard deviation (SD)], therapy, treatment compliance, symptoms, frequency of hospital admissions and, at the last visit, growth and biochemical work-up of 29 patients followed for at least 6 months were analysed. Quality of life items were also assessed by a questionnaire.
RESULTS: Muscle cramps (41%) and asthenia (35%) were the most frequent presenting symptoms. Biochemical data at diagnosis were serum K 2.76 ± 0.46 mEq/L, serum Mg 1.32 ± 0.28 mg/dL, blood pH 7.45 ± 0.06, serum bicarbonate 28.2 ± 2.9 mEq/L, urinary calcium/creatinine ratio 0.03 ± 0.04 mg/mg, fractional K excretion 24.4 ± 17.1% and fractional Mg excretion 8.9 ± 8.3%. During follow-up, Mg and K supplements were prescribed to 79 and 86% of patients, respectively; compliance with treatment was good in 35%. Hospital admission rate was 0.03/patient/month. Muscle cramps were the symptom most often referred by the patients (45%) during the follow-up, and 71% of patients considered their health status as excellent or good. Twenty-one patients stated that their disease did not adversely interfere with their mood or social relationships. Height and weight of patients at diagnosis were -0.60 ± 1.17 and -0.49 ± 1.32 SD, respectively, and improved to -0.44 ± 1.28 (P < 0.05) and 0.18 ± 1.79 SD (P < 0.01) at the last visit.
CONCLUSIONS: Gypsy children with Gitelman syndrome mostly exhibit muscle symptoms and asthenia although the disease is not particularly severe in this ethnic group. Body growth improves with treatment and close follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571093     DOI: 10.1093/ndt/gfq352

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Gitelman syndrome: novel mutation and long-term follow-up.

Authors:  Aditi Sinha; Petr Lněnička; Biswanath Basu; Ashima Gulati; Pankaj Hari; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2011-10-04       Impact factor: 2.801

2.  Fanconi syndrome and severe polyuria: an uncommon clinicobiological presentation of a Gitelman syndrome.

Authors:  Karim Bouchireb; Olivia Boyer; Lamisse Mansour-Hendili; Arnaud Garnier; Laurence Heidet; Patrick Niaudet; Remi Salomon; Rosa Vargas Poussou
Journal:  BMC Pediatr       Date:  2014-08-11       Impact factor: 2.125

3.  Clinical and Genetic Characteristics in Patients With Gitelman Syndrome.

Authors:  Junya Fujimura; Kandai Nozu; Tomohiko Yamamura; Shogo Minamikawa; Keita Nakanishi; Tomoko Horinouchi; China Nagano; Nana Sakakibara; Koichi Nakanishi; Yuko Shima; Kenichi Miyako; Yoshimi Nozu; Naoya Morisada; Hiroaki Nagase; Takeshi Ninchoji; Hiroshi Kaito; Kazumoto Iijima
Journal:  Kidney Int Rep       Date:  2018-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.